Crescent Biopharma CBIO
NASDAQ CBIO
$14.76 +0.23 (+1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Operating Expenses (2013 - 2026)

Updated

Crescent Biopharma's Operating Expenses was $28.13 million in Q2 2026, up 33.8% from $21.03 million a year earlier and up 9.2% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Operating Expenses (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Crescent Biopharma's Operating Expenses was $182.12 million through Jun 30, 2026, up 186.0% year-over-year; for FY2025, it was $163.48 million, up 308.3% from FY2024.

  • Operating Expenses shows a five-year compound annual growth rate of 21.5% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $40.04 million in FY2024 (+1.9%), $39.29 million in FY2023 (-17.3%), $47.48 million in FY2022 (-26.5%) and $64.61 million in FY2021 (+4.8%).
  • Quarterly Operating Expenses has moved between $8.77 million (Q3 2022) and $102.34 million (Q4 2025) over five years.
  • Compared with a year earlier, Operating Expenses has increased for ten straight quarters, with growth averaging 120.6% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2025 (growth of 495.3%); the worst was Q3 2022 (a decline of 49.7%).
  • Per Business Quant data, CBIO's Operating Expenses in the three quarters before Q2 2026 was $25.77 million (Q1 2026), $102.34 million (Q4 2025) and $25.89 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Crescent Biopharma 403.30 Mn -304.00 Mn - 28.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.13 Mn
Mar 31, 2026 25.77 Mn
Dec 31, 2025 102.34 Mn
Sep 30, 2025 25.89 Mn
Jun 30, 2025 21.03 Mn
Mar 31, 2025 14.22 Mn
Dec 31, 2024 17.19 Mn
Sep 30, 2024 11.23 Mn
Jun 30, 2024 10.36 Mn
Mar 31, 2024 11.12 Mn
Dec 31, 2023 9.60 Mn
Sep 30, 2023 9.81 Mn
Jun 30, 2023 8.93 Mn
Mar 31, 2023 10.94 Mn
Dec 31, 2022 10.62 Mn
Sep 30, 2022 8.77 Mn
Jun 30, 2022 13.43 Mn
Mar 31, 2022 14.66 Mn
Dec 31, 2021 17.44 Mn
Sep 30, 2021 17.42 Mn
API Access

Crescent Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CBIO&period=max&api_key=YOUR_API_KEY